Literature DB >> 28572217

Targeting limited NHS resources to affect optimal care.

Ed Nicol1.   

Abstract

Mesh：

Year:  2017        PMID： 28572217      PMCID： PMC6297558          DOI： 10.7861/clinmedicine.17-3-195

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  7 in total

1.  The 2016 update to NICE CG95 guideline for the -investigation of new onset stable chest pain: more -innovation, but at a cost?

Authors:  Khaled Alfakih; John P Greenwood; Sven Plein
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

Review 2.  Developments in therapy with monoclonal antibodies and related proteins.

Authors:  H Michael Shepard; Gail Lewis Phillips; Christopher D Thanos; Marc Feldmann
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

3.  Drug therapy in anticoagulation: which drug for which patient?

Authors:  Carolyn M Millar; Mike A Laffan
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

4.  Is replacement modality choice knowledge important in the non-renal multidisciplinary team? Experience from a single UK centre.

Authors:  Fatima Abdelaal; Hatem Ali; Jyoti Baharani
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

5.  mSOAR: an effective bedside stroke prognosis tool.

Authors:  Mark Thaller; Nicholas Mitchell
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

6.  Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease.

Authors:  Michelle C Williams; Amanda Hunter; Anoop S V Shah; Valentina Assi; Stephanie Lewis; Joel Smith; Colin Berry; Nicholas A Boon; Elizabeth Clark; Marcus Flather; John Forbes; Scott McLean; Giles Roditi; Edwin J R van Beek; Adam D Timmis; David E Newby
Journal:  J Am Coll Cardiol       Date:  2016-04-19       Impact factor: 24.094

Review 7.  Adrenal insufficiency - recognition and management.

Authors:  Agnieszka Pazderska; Simon Hs Pearce
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.